Monitoring and fault detection of continuous glucose sensor measurements

Faults in subcutaneous glucose concentration readings can cause the computation of insulin infusion rates that can lead to hypoglycemia or hyperglycemia in artificial pancreas control systems for patients with type 1 diabetes (T1D). In this paper, multivariable statistical monitoring methods are used for detection of faults in glucose concentration values reported by a glucose sensor. Multiway principal component analysis is used to develop a model that describes the expected variation in glucose readings under normal conditions. Various meal scenarios are defined to generate different data-sets using the UVa/Padova metabolic simulator. Dynamic time warping is used for synchronization of different scenarios. Different faults such as step, random, drift and exponential changes are tested. The results show that the proposed method is able to detect various types of faults with high accuracy. Detailed analysis of sensitivity, false detection ratio and detection time for different fault types is also presented. The proposed fault detection algorithm can decrease the effects of faults on insulin infusion rates and reduce the potential for hypo- or hyperglycemia for patients with T1D.

[1]  A BuckinghamBruce,et al.  Remote Glucose Monitoring in Camp Setting Reduces the Risk of Prolonged Nocturnal Hypoglycemia , 2014 .

[2]  L. Magni,et al.  Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.

[3]  Irl B. Hirsch,et al.  Multivariable adaptive identification and control for artificial pancreas systems , 2015 .

[4]  E. Atlas,et al.  Night glucose control with MD‐Logic artificial pancreas in home setting: a single blind, randomized crossover trial—interim analysis , 2014, Pediatric diabetes.

[5]  J. Stockman,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2011 .

[6]  Raghunathan Rengaswamy,et al.  A review of process fault detection and diagnosis: Part I: Quantitative model-based methods , 2003, Comput. Chem. Eng..

[7]  B. Wayne Bequette,et al.  Detecting sensor and insulin infusion set anomalies in an artificial pancreas , 2013, 2013 American Control Conference.

[8]  Ali Cinar,et al.  Chemical Process Performance Evaluation , 2007 .

[9]  K. Turksoy,et al.  Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. , 2013, Diabetes technology & therapeutics.

[10]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[11]  Josep Vehí,et al.  Detection of Correct and Incorrect Measurements in Real-Time Continuous Glucose Monitoring Systems by Applying a Postprocessing Support Vector Machine , 2013, IEEE Transactions on Biomedical Engineering.

[12]  Raghunathan Rengaswamy,et al.  A review of process fault detection and diagnosis: Part II: Qualitative models and search strategies , 2003, Comput. Chem. Eng..

[13]  Ali Cinar,et al.  Statistical monitoring of multistage, multiphase batch processes , 2002 .

[14]  Raghunathan Rengaswamy,et al.  A review of process fault detection and diagnosis: Part III: Process history based methods , 2003, Comput. Chem. Eng..

[15]  Germán Campetelli,et al.  Improvements on Noninvasive Blood Glucose Biosensors Using Wavelets for Quick Fault Detection , 2011, J. Sensors.

[16]  Josep Vehí,et al.  Principal component analysis in combination with case-based reasoning for detecting therapeutically correct and incorrect measurements in continuous glucose monitoring systems , 2013, Biomed. Signal Process. Control..

[17]  B Wayne Bequette,et al.  Fault Detection and Safety in Closed-Loop Artificial Pancreas Systems , 2014, Journal of diabetes science and technology.

[18]  Ali Cinar,et al.  An Integrated Multivariable Artificial Pancreas Control System , 2014, Journal of diabetes science and technology.

[19]  Ahmad Haidar,et al.  Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes , 2013, Diabetes Care.

[20]  David M Nathan,et al.  Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. , 2014, The Journal of clinical endocrinology and metabolism.

[21]  Giovanni Sparacino,et al.  Detecting failures of the glucose sensor-insulin pump system: Improved overnight safety monitoring for Type-1 diabetes , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[22]  John F. MacGregor,et al.  Multi-way partial least squares in monitoring batch processes , 1995 .

[23]  C. C. Palerm,et al.  Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery , 2009, Diabetes Care.

[24]  Quan Shen,et al.  Online dropout detection in subcutaneously implanted continuous glucose monitoring , 2010, Proceedings of the 2010 American Control Conference.

[25]  D. BretonMarc,et al.  Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. , 2014 .

[26]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[27]  Marc D Breton,et al.  Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. , 2014, Diabetes technology & therapeutics.

[28]  J Geoffrey Chase,et al.  Using Stochastic modelling to identify unusual continuous glucose monitor measurements and behaviour, in newborn infants , 2012, Biomedical engineering online.

[29]  Josep Vehí,et al.  Using Support Vector Machines to Detect Therapeutically Incorrect Measurements by the MiniMed CGMS® , 2008, Journal of diabetes science and technology.

[30]  Marc D. Breton,et al.  Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas , 2014, Diabetes Care.